rs377767376
Positions:
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PVS1_StrongPM2PP5_Moderate
The NM_005359.6(SMAD4):c.1587dup(p.His530ThrfsTer47) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★). Synonymous variant affecting the same amino acid position (i.e. L529L) has been classified as Likely benign.
Frequency
Genomes: not found (cov: 32)
Consequence
SMAD4
NM_005359.6 frameshift
NM_005359.6 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.100
Genes affected
SMAD4 (HGNC:6770): (SMAD family member 4) This gene encodes a member of the Smad family of signal transduction proteins. Smad proteins are phosphorylated and activated by transmembrane serine-threonine receptor kinases in response to transforming growth factor (TGF)-beta signaling. The product of this gene forms homomeric complexes and heteromeric complexes with other activated Smad proteins, which then accumulate in the nucleus and regulate the transcription of target genes. This protein binds to DNA and recognizes an 8-bp palindromic sequence (GTCTAGAC) called the Smad-binding element (SBE). The protein acts as a tumor suppressor and inhibits epithelial cell proliferation. It may also have an inhibitory effect on tumors by reducing angiogenesis and increasing blood vessel hyperpermeability. The encoded protein is a crucial component of the bone morphogenetic protein signaling pathway. The Smad proteins are subject to complex regulation by post-translational modifications. Mutations or deletions in this gene have been shown to result in pancreatic cancer, juvenile polyposis syndrome, and hereditary hemorrhagic telangiectasia syndrome. [provided by RefSeq, May 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. There are 13 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 18-51078394-T-TA is Pathogenic according to our data. Variant chr18-51078394-T-TA is described in ClinVar as [Pathogenic]. Clinvar id is 24867.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SMAD4 | NM_005359.6 | c.1587dup | p.His530ThrfsTer47 | frameshift_variant | 12/12 | ENST00000342988.8 | |
SMAD4 | NM_001407041.1 | c.1587dup | p.His530ThrfsTer47 | frameshift_variant | 12/12 | ||
SMAD4 | NM_001407042.1 | c.1587dup | p.His530ThrfsTer47 | frameshift_variant | 12/12 | ||
SMAD4 | NR_176265.1 | n.2238dup | non_coding_transcript_exon_variant | 13/13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SMAD4 | ENST00000342988.8 | c.1587dup | p.His530ThrfsTer47 | frameshift_variant | 12/12 | 5 | NM_005359.6 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Juvenile polyposis syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 24, 2020 | This sequence change results in a frameshift in the SMAD4 gene (p.His530Thrfs*47). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 23 amino acids of the SMAD4 protein and extend the protein by an additional 24 amino acids. This variant is not present in population databases (ExAC no frequency). This variant has been reported in an individual affected with juvenile polyposis syndrome (PMID: 18178612, 26572829). It has also been observed to be de novo in an individual affected with juvenile polyposis and hereditary hemorrhagic telangiectasia syndrome (Invitae). This variant is also known as c.1586_1587dupA (p.L529LfsX9) in the literature. ClinVar contains an entry for this variant (Variation ID: 24867). For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at